Home › Breast Cancer › NCT05598879
Global Cardio Oncology Registry
Who can join
Ages 18 and older · All sexes
Full eligibility criteria
Inclusion Criteria: * New cardio-oncology consultation for breast cancer patients, or * New cardio-oncology consultation for Hodgkin's or non-Hodgkin's lymphoma patients, or * New cardio-oncology consultation for acute or chronic leukemia patients, or * New cardio-oncology consultation for multiple myeloma or AL amyloidosis, or * New cardio-oncology consultations for immune check-point inhibitors cardiac evaluation. * All patients have to be 18 years old or older Exclusion Criteria: * Cardio-oncology patients who have previously had cardio-oncology evaluation and follow up by the investigators. * Minors less than 18 years old. * Inability or unwillingness to consent to participate
About the study
G-COR is the first Global Prospective Cardio-Oncology Registry. It is a multinational, multicenter prospective observational cohort registry, with the goal of collecting clinical, laboratory, imaging, demographic, and socioeconomic data to identify risk factors associated with increased incidence of cancer therapy related cardiovascular toxicity (CTR-CVT) in different settings and to derive and validate risk scores for cardio oncology patients treated in different geographic locations throughout the world.
What is being tested
- anonymized data collection during programmed surveillance clinical follow up (other)
Sponsor: The Cleveland Clinic · Participants: 5,000 · Started: Jul 1, 2022
Contact the study team
- Diego Sadler, MD FACC · Phone: 5613898833
- Rohit Moudgil, MD PhD · Phone: 216-445-1932
Official record on ClinicalTrials.gov — NCT05598879
Locations in the U.S.
| Florida | Cleveland Clinic Florida, Weston |
Conditions
From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.